Table 1. Baseline clinical characteristics of healthy volunteer- and atherosclerotic patient-derived EPCs.
Healthy volunteers | Atherosclerotic patients | ||
(n = 10) | (n = 10) | ||
Age (yrs) | 34.4±1.4 | 74.2±2.7 | P<0.001 |
Gender | |||
Male | 8 | 8 | N.S |
Female | 2 | 2 | N.S |
Hypertension | 0 | 9 | P<0.001 |
Dyslipidemia | 0 | 8 | P<0.005 |
Diabetes mellitus | 0 | 4 | P<0.05 |
Smoking | 2 | 7 | P<0.05 |
Medication | |||
RASi | 0 | 5 | P<0.05 |
Statin | 0 | 8 | P<0.001 |
RASi = renin-angiotensin system inhibitor. Data are presented as the mean ± SEM.